Through an intuitive cataloging database, we have made available to the global scientific community the ability to review the available inventory of samples related to diabetes and metabolic disorders.
Specifically, a catalog of pluripotent stem cell lines and fibroblast cells lines derived from carefully phenotyped patients with various types of diabetes, primarily those with the type 1 form of this disease. Our goal is to provide novel insights into the pathogenesis and treatment of diabetes and other metabolic disorders, including obesity.
We believe that this cell hub will ultimately serve as the premier resource for scientists performing research on diabetes using stem cells.
We provide novel insights into the pathogenesis and treatment of diabetes.